Physostigmine: Is there a role for this antidote in pediatric poisonings?

Current Opinion in Pediatrics

Volumn 19, Issue 2, 2007, Pages 201-205

  Frascogna, Nan ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Anticholinergic; Gamma hydroxybutyrate; Ingestion; Physostigmine; Tricyclic antidepressants

Indexed keywords

4 HYDROXYBUTYRIC ACID; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATROPINE; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOBENZAPRINE; CYCLOPENTOLATE; DIPHENHYDRAMINE; DOXYLAMINE; HYDROXYZINE; HYOSCYAMINE; IMIPRAMINE; NEOSTIGMINE; OLANZAPINE; OXYBUTYNIN; PHENOTHIAZINE DERIVATIVE; PHYSOSTIGMINE; PHYSOSTIGMINE SALICYLATE; PROMETHAZINE; SCOPOLAMINE; STRAMONIUM; TRIHEXYPHENIDYL; TROPICAMIDE;

AGITATION; ASPIRATION PNEUMONIA; BRADYCARDIA; CHOLINERGIC SYSTEM; CLINICAL FEATURE; DELIRIUM; DIAPHORESIS; DIARRHEA; DRUG EFFICACY; DRUG OVERDOSE; DRUG SAFETY; ENDOTRACHEAL INTUBATION; FECES INCONTINENCE; HEART ARRHYTHMIA; HUMAN; INTOXICATION; MUSHROOM; NERVE CELL STIMULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; SECRETION; SEDATION; SEIZURE; SIDE EFFECT; TREATMENT CONTRAINDICATION; VOMITING;

ANTIDOTES; CHILD; CHOLINERGIC ANTAGONISTS; CHOLINESTERASE INHIBITORS; HUMANS; PHYSOSTIGMINE; POISONING;

EID: 34247630492     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32802c7be1     Document Type: Review

References (16)

1. Watson WA, Litovitz TL, Rodgers GC, et al. 2004 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005; 23:589-666. This report describes the epidemiology of all reported potential toxic exposures in the United States by poison control centers.
2. Pentel P, Peterson CD. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med 1980; 9:588-590.
3. Shannon M. Toxicology reviews: physostigmine. Pediatric Emergency Care 1998; 14:224-225.
4. th ed. New York: McGraw-Hill; 2006. pp. 794-797.
5. Newton R. Physostigmine salicylate in the treatment of tricyclic antidepressant overdosage. JAMA 1975; 231:941-943.
6. Burns MJ, Linden CH, Graudins A, Brown RM, Fletcher KE. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med 2000; 35:374-381.
7. Schneir AB, Offerman SR, Ly BT, et al. Complications of diagnostic physostigmine administration to emergency department patients. Ann Emerg Med 2003; 42:14-19.
8. Suchard J. Assessing physostigmine's contraindication in cyclic antidepressant ingestions. J Emerg Med 2003; 25:185-191.
9. Knudsen K, Heath A. Effects of self-poisoning with maprotiline. BMJ 1984; 288:601-603.
10. Henderson RS, Holmes CM. Reversal of the anesthetic action of sodium gamma-hydroxybutyrate. Anesthesiol Intensive Care 1976; 4:351-354.
11. Caldicott D, Kuhn M. Gamma-hydroxybutyrate overdose and physostigmine: teaching new tricks to an old drug? Ann Emerg Med 2001; 37:99-102.
12. Sethy VH, Roth RH, Walters JR, et al. Effect of anesthetic doses of gamma-hydroxybutyrate on the acetylcholine content of rat brain. Naunyn Schmiedebergs Arch Pharmacol 1976; 295:9-14.
13. Traub S, Nelson L, Hoffman R. Physostigmine as a treatment for gamma-hydroxybutyrate toxicity: a review. J Toxicol Clin Tox 2002; 40:781-787.
14. Kleinschmidt S, Schellhase C, Mertzlufft F. Continuous sedation during spinal anesthesia: gamma-hydroxybutyrate vs. propofol. Eur J Anesthesiol 1999; 16:23-30.
15. Bania TC, Chu J. Physostigmine does not effect arousal but produces toxicity in an animal model of severe gamma-hydroxybutyrate intoxication. Acad Emerg Med 2005; 12:185-189. The authors describe an animal model of GHB intoxication and effects of physostigmine as a reversal agent.
16. Fleischer G, Ludwig S, Henretig F. Textbook of pediatric emergency medicine. Philadelphia: Lippincott Williams & Wilkins; 2006.